Microbot Medical (MBOT) Sees Large Volume Increase
Microbot Medical Inc (NASDAQ:MBOT) shares saw an uptick in trading volume on Thursday . 4,017,894 shares traded hands during mid-day trading, an increase of 353% from the previous session’s volume of 887,524 shares.The stock last traded at $1.05 and had previously closed at $1.02.
In related news, Director Moshe Shoham sold 33,700 shares of the stock in a transaction that occurred on Monday, October 9th. The shares were sold at an average price of $1.50, for a total value of $50,550.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Yoseph Bornstein sold 50,000 shares of the stock in a transaction that occurred on Tuesday, September 26th. The shares were sold at an average price of $1.24, for a total transaction of $62,000.00. The disclosure for this sale can be found here. Insiders sold 508,234 shares of company stock worth $616,599 over the last 90 days. 31.83% of the stock is currently owned by company insiders.
An institutional investor recently bought a new position in Microbot Medical stock. Sabby Management LLC bought a new position in Microbot Medical Inc (NASDAQ:MBOT) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 1,285,351 shares of the biotechnology company’s stock, valued at approximately $1,825,000. Sabby Management LLC owned 2.92% of Microbot Medical as of its most recent filing with the Securities & Exchange Commission. 4.72% of the stock is owned by institutional investors.
Microbot Medical Company Profile
Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.
Receive News & Stock Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related stocks with our FREE daily email newsletter.